C. difficile (C. diff) is a contagious bacteria (germ) that infects the colon (large intestine) and can cause diarrhea and other health complications. People who have chronic conditions and frequently visit healthcare facilities are at greater risk of C. diff infection due to increased exposure and weakened immune systems.
The BEETHOVEN study will help us learn if an investigational vaccine is safe and can help prevent C. diff infection in people [65] years of age or older.
Who can take part?#
This clinical trial may be an option if you have had 10 or more healthcare visits in the last year and have not previously had C. diff. You may also qualify if you have one of the following risk factors for infection:
•Have received antibiotics in the last 3 months
•Have been hospitalized at least once or had 2 emergency room visits in the last year
•Are scheduled to be hospitalized or have elective surgery
There are other requirements that the study team will discuss with you.
What to expect#
You will receive 2 doses of the investigational C. diff vaccine or placebo (injection with no vaccine).
Participation lasts for up to 3 and a half years and includes at least 8 study visits.
There is no cost to participate. [You will be paid for completing some clinical trial activities.]
Ready to learn more?#
For more information, contact our study team.
786-772-0510
